Jeon Hong Ryeol,Kang Yoon-Mo,Lee Byeong-Gon,Kim Se-Young,Shin Go-Eun
申请号：
US201414895886
公开号：
US10004769(B2)
申请日:
2014.06.02
申请国别(地区):
美国
年份:
2018
代理人:
Knobbe Martens Olson & Bear LLP
摘要：
The present invention relates to a novel Lactobacillus brevis G-101 strain capable of decomposing monosodium L-glutamate (MSG), and a functional health food, a pharmaceutical composition, or a food product comprising the same as an active ingredient. More specifically, the strain is effective in reducing in vivo blood MSG levels of animals and attenuating MSG Symptom Complex, and thus can be used in a functional health food, a pharmaceutical composition, or a food product aiming to prevent in vivo absorption of MSG, which is known to be harmful, and improve the MSG Symptom Complex.
